Synthesis and antimalarial activity of hydroxyethylpiperazine derivatives.

Eur J Med Chem

Fundação Oswaldo Cruz, Instituto de Tecnologia em Fármacos, Farmanguinhos R. Sizenando Nabuco, 100, Manguinhos, 21041-250 Rio de Janeiro, RJ, Brazil.

Published: March 2009

The antimalarial activity of hydroxyethylpiperazine derivatives, synthesized from the reaction of (2S,3S)Boc-phenylalanine epoxide with benzylpiperazines in good yields (76-96%), has been evaluated in vitro against the Plasmodium falciparum W2 clone (chloroquine resistant). The results show that some compounds have moderate activity against this parasite and none of the active compounds showed cytotoxicity at high concentration (100 microg/ml).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2008.04.009DOI Listing

Publication Analysis

Top Keywords

antimalarial activity
8
activity hydroxyethylpiperazine
8
hydroxyethylpiperazine derivatives
8
synthesis antimalarial
4
derivatives antimalarial
4
derivatives synthesized
4
synthesized reaction
4
reaction 2s3sboc-phenylalanine
4
2s3sboc-phenylalanine epoxide
4
epoxide benzylpiperazines
4

Similar Publications

Design and synthesis of novel triazine derivatives as antimalarial agents.

Bioorg Med Chem Lett

December 2024

Carna Biosciences, Inc., 1-5-5 Minatojima-Minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan.

In a previous study, we reported that nilotinib, a BCR-ABL tyrosine kinase inhibitor, possesses moderate antimalarial activity against PfK1 and PfFCR3. As a part of our efforts to develop novel antimalarial agents, a series of novel triazine analogs was identified as potent antimalarial agents via structure modification of nilotinib. Compound 15a showed strong antimalarial activities against PfK1 and PfFCR3 with IC values of 0.

View Article and Find Full Text PDF

C(sp3)-H Bond Functionalization of 8-Methylquinolines.

Chem Asian J

December 2024

CSIR-IHBT: Institute of Himalayan Bioresource Technology CSIR, Chemical Technology, Palampur, India, Palampur, 176061, Palampur, INDIA.

Quinolines have emerged as essential components in various medicinal agents, playing a key role in treating various ailments. Numerous drugs with a quinoline core have been recognized for their antimalarial, antibacterial, and anticancer activities and have been successfully commercialized, including chloroquine, ciprofloxacin, topotecan, etc. Over the past two decades, we have witnessed a tremendous expansion in the C-H bond functionalization of quinoline scaffolds to widen this chemical space for drug discovery further.

View Article and Find Full Text PDF

Background: The dysregulation of ribosome biogenesis has been extensively identified in various cancers, making it emerge as a hallmark of malignant cells. This highlights the potential of targeting ribosome biogenesis as an effective approach for treating cancer patients. Although chemotherapy drugs including doxorubicin and cisplatin often target ribosome biogenesis to induce DNA damage or inhibit tumor cell proliferation, they are associated with significant side effects.

View Article and Find Full Text PDF

Introduction: Malaria caused by spp. is the most hazardous disease in the world. It is regarded as a life-threatening hematological disorder caused by parasites transferred to humans by the bite of Anopheles mosquitoes.

View Article and Find Full Text PDF

Substrate and inhibitor specificity of Plasmodium nucleoside transporters ENT1 orthologues.

J Biol Chem

December 2024

Department of Obstetrics, Key Laboratory of Birth Defects and Related Disease of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University, Chengdu 610041, China; NHC key Laboratory of Chronobiology, Sichuan University, Chengdu 610041, China. Electronic address:

Malaria caused by Plasmodium infection poses a serious hazard to human health. P. falciparum equilibrative nucleoside transporter 1 (PfENT1), which mediates nucleoside uptake, is essential for the growth and proliferation of Plasmodium parasites, suggesting that PfENT1 is a potential antimalarial target.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!